Difference between revisions of "Esmolol"

From Dog
(Created page with "Esmolol is a selective β<sub>1</sub> antagonist with rapid onset and short duration. In dogs, it is commonly used to treat tachycardia associated with drug overdoses (e.g. [...")
 
Line 3: Line 3:
 
In dogs, it is commonly used to treat tachycardia associated with drug overdoses (e.g. [[phenylpropanolamine]])<ref>Ginn JA ''et al'' (2013) Systemic hypertension and hypertensive retinopathy following PPA overdose in a dog. ''J Am Anim Hosp Assoc'' '''49(1)''':46-53</ref>.
 
In dogs, it is commonly used to treat tachycardia associated with drug overdoses (e.g. [[phenylpropanolamine]])<ref>Ginn JA ''et al'' (2013) Systemic hypertension and hypertensive retinopathy following PPA overdose in a dog. ''J Am Anim Hosp Assoc'' '''49(1)''':46-53</ref>.
  
Recommended dose rate in dogs is 0.05 mg/kg given intravenously as a loading dose, followed by 50 - 200 µg/kg per min.
+
Recommended dose rate in dogs is 0.05 mg/kg given intravenously as a loading dose, followed by 50 - 200 µg/kg per min<ref>Hori, Y ''et al'' (2009) The relationship between invasive hemodynamic measurements and tissue Doppler-derived myocardial velocity and acceleration during isovolumic relaxation in healthy dogs. ''J Vet Med Sci'' '''71(11)''':1419-1425</ref>.
  
 
==References==
 
==References==
 
<References/>
 
<References/>

Revision as of 00:39, 10 April 2013

Esmolol is a selective β1 antagonist with rapid onset and short duration.

In dogs, it is commonly used to treat tachycardia associated with drug overdoses (e.g. phenylpropanolamine)[1].

Recommended dose rate in dogs is 0.05 mg/kg given intravenously as a loading dose, followed by 50 - 200 µg/kg per min[2].

References

  1. Ginn JA et al (2013) Systemic hypertension and hypertensive retinopathy following PPA overdose in a dog. J Am Anim Hosp Assoc 49(1):46-53
  2. Hori, Y et al (2009) The relationship between invasive hemodynamic measurements and tissue Doppler-derived myocardial velocity and acceleration during isovolumic relaxation in healthy dogs. J Vet Med Sci 71(11):1419-1425